trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Side effects of flu vaccines are usually mild and go away on their own within a few days.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that side effects of flu vaccines are usually mild and go away on their own within a few days?

Yes. Side effects from flu vaccines are typically mild and resolve on their own within a few days.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently indicates that the side effects associated with seasonal influenza vaccines (whether traditional or newer mRNA platforms) are predominantly mild, transient, and resolve without intervention. Multiple cross-sectional studies and clinical trial safety profiles support this consensus, and no retrieved papers refute the claim.

Evidence for · 4
Knowledge, Attitudes, and Practices of Influenza Vaccination among Parents of Children with Asthma: A Cross-Sectional Study.
2023
Most participants who received the flu vaccine reported that side effects were mild.
Get citation
W, A., A, J., A, H., F, A., J, L., E, A., M, A., B, A., & L, H. (2023). Knowledge, Attitudes, and Practices of Influenza Vaccination among Parents of Children with Asthma: A Cross-Sectional Study.. doi.org. https://doi.org/10.3390/vaccines11061074

See more details
More for · 3
Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices.
2023
Studies examining flu vaccination among asthmatic adults similarly found that the majority of vaccinated individuals experienced only mild side effects.
Get citation
W, A., A, A., A, J., AQ, A. B., A, H., F, A., B, A., D, A. H., N, A. M., & J, E. (2023). Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices.. doi.org. https://doi.org/10.2147/ppa.s436622

Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged ≥50 years in Japan.
2026
Clinical evaluations of new mRNA-based seasonal influenza vaccines show that solicited adverse reactions are predominantly mild to moderate and transient.
Get citation
L, K., H, F., A, R., K, H., S, O., & O, K. (2026). Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged ≥50 years in Japan.. doi.org. https://doi.org/10.1016/j.vaccine.2026.128961

mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety.
2026
Reviews of mRNA seasonal influenza vaccines confirm that adverse reactions align with standard profiles and are predominantly mild-to-moderate and transient.
Get citation
A, D. & A, O. (2026). mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety.. doi.org. https://doi.org/10.3389/fimmu.2026.1965512

What does the evidence say?

The retrieved literature consistently indicates that the side effects associated with seasonal influenza vaccines (whether traditional or newer mRNA platforms) are predominantly mild, transient, and resolve without intervention. Multiple cross-sectional studies and clinical trial safety profiles support this consensus, and no retrieved papers refute the claim.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work